Co-Authors
This is a "connection" page, showing publications co-authored by Kazuo Takayama and Ángel Serrano-Aroca.
Connection Strength
1.117
-
SARS-CoV-2 research using human pluripotent stem cells and organoids. Stem Cells Transl Med. 2021 11; 10(11):1491-1499.
Score: 0.240
-
Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era. ACS Nano. 2021 05 25; 15(5):8069-8086.
Score: 0.235
-
Protective Face Mask Filter Capable of Inactivating SARS-CoV-2, and Methicillin-Resistant Staphylococcus aureus and Staphylococcus epidermidis. Polymers (Basel). 2021 Jan 08; 13(2).
Score: 0.231
-
Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care. Mater Lett. 2021 Dec 01; 304:130612.
Score: 0.060
-
The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19. Autoimmun Rev. 2021 10; 20(10):102909.
Score: 0.060
-
COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? Biomolecules. 2021 07 13; 11(7).
Score: 0.060
-
Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2. Int J Biol Macromol. 2021 Jun 30; 181:801-809.
Score: 0.059
-
A unique view of SARS-CoV-2 through the lens of ORF8 protein. Comput Biol Med. 2021 06; 133:104380.
Score: 0.059
-
The structural basis of accelerated host cell entry by SARS-CoV-2†. FEBS J. 2021 09; 288(17):5010-5020.
Score: 0.057
-
Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features. Molecules. 2020 Dec 13; 25(24).
Score: 0.057